Control of Emergence Blood Pressure During Craniotomy for Tumor Surgery Between Labetolol and Diltiazem
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 184 participants.
Also called NCT01408524
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 184 participants
- Sponsor
- Registry
-
NCT01408524
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01408524. Randomized; quadruple masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2012-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Control of Emergence Blood Pressure During Craniotomy for Tumor Surgery Between Labetolol and Diltiazem
- Condition
- Hypertension
- Condition
- Craniotomy
- Intervention (Drug)
- Diltiazem
- Intervention (Drug)
- Labetalol
- Lead sponsor
- Mahidol University
Record details
- Record id
cardio:ct-nct01408524- Content hash
b1fedbbff168eefd3e27de29cfc9dfacdb458d63eaccfdc9f996cfbffd2f7746